A Cairo-based healthtech startup focused on providing mental health services in the Middle East and North Africa (MENA) has just secured one of the largest investment rounds for its sector in the region.
O7 Therapy – a digital platform and smartphone app that specialises in online therapy, corporate wellness programmes, and psychoeducational resources for “Arabic-speaking users” – has raised a...
Pillo Health, maker of conversational devices and platforms for medication adherence, has closed a $11 million Series A round led by Stanley Black & Decker’s Stanley Ventures with “significant participation” from Samsung Ventures. Existing backers BioAdvance, Hikma Ventures, Hackensack Meridien Health System’s Innovation Center Fund and Civilization Ventures also took part in the funding....
San Francisco-based Lemonaid Health, which offers a simple, text-based telemedicine app, has raised $11 million in Series A funding. Novartis Venture Fund and Hikma Ventures led the round, with participation from Correlation Ventures, Adaptive Healthcare Fund, Vega Ventures and 415 Ventures. The company last received funding in 2015, and the latest investment brings Lemonaid’s total capital to...
Madison, Wisconsin-based Propeller Health has closed a $21.5 million Series C financing round, with new investors 3M Ventures, S.R. One, Limited and Hikma Ventures, plus existing investors Safeguard Scientifics and Social Capital. The funding will be used to further Propeller’s digitally-guided therapy platform.
Propeller’s aim is to simplify management of chronic respiratory diseases like asthma...
Hayward, California-based Chrono Therapeutics, which is developing a sensor-enabled nicotine patch with a connected app, has raised $47.6 million in Series B financing. The round was led by Kaiser Permanente Ventures and will go towards further development of the company’s digital drug therapy platform.
Chrono Therapeutics’ flagship product, which won’t be ready for consumers until as late as...
